Registry study for children with HLH
Part of Blood & lymphatic clinical trials.
This study is a disease registry that collects medical information from children who have hemophagocytic lymphohistiocytosis (HLH) or are suspected to have it. It helps doctors better understand HLH and how it affects patients over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have HLH that is confirmed or strongly suspected
- You may meet HLH-2004 criteria, or you may have a related HLH condition (like MAS or CRS)
- The study is for children (including teens who can assent)
- A parent/guardian must sign and date consent for you
- Teens may need to sign and date assent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults who have findings that suggest HLH, a serious immune problem. It may help doctors better understand the condition by tracking patients over time and comparing symptoms and test results.
This trial looks at how people with lymphoma-related hemophagocytic lymphohistiocytosis (HLH) respond to treatment. It aims to better describe expected outcomes and who benefits most, which may help guide future care.
This study looks at specific immune cells (T cells) in people who have a rare condition called Hemophagocytic Lymphohistiocytosis (HLH) together with an aggressive lymphoma. It aims to better understand how these cells behave, which may lead to improved diagnosis or treatment.
This study collects information and may collect fresh tumor tissue to better understand and model relapsed or hard-to-treat liver tumors. Joining could help researchers develop future treatments and more personalized research for affected patients.
This study is for people with hemophagocytic lymphohistiocytosis (HLH), a condition where the immune system becomes overactive. Researchers want to collect medical data and blood samples to better understand HLH and find better ways to diagnose and treat it.
This study is a registry that collects information about people with certain types of leukemia. It may help researchers understand the disease course and how patients are treated, including people who are newly diagnosed, currently treated, referred for transplant, or have relapsed.
Hear when a new Hemophagocytic Lymphohistiocytoses trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.